JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A3573 LY2801653

Target: MET

Summary: MET inhibitor

≥27.65 mg/mL
B1438 BMS-794833

Target: MET|Flk-1

Summary: Met/VEGFR-2 inhibitor,potent and ATP-competitive

≥23.45 mg/mL
A2678 SU11274
2 Citation

Target: MET

Summary: C-Met inhibitor,potent and selective

≥28.4 mg/mL
A1196 SGX-523
1 Citation

Target: MET

Summary: MET inibitor, highly selective, ATP-competitive

≥17.95 mg/mL
A5703 BMS-777607

Target: MET

Summary: C-Met inhibitor, potent and selective

≥25.65 mg/mL
A8325 Tivantinib (ARQ 197)
2 Citation

Target: MET

Summary: C-Met inhibitor,non-ATP-competitive

≥18.47 mg/mL
A8476 MK-2461

Target: FLT3|PDGFR|MET|Ron

Summary: C-Met (WT/mutants) inhibitor

≥24.8 mg/mL